Skip to main content
. 2022 Jan 21;10(5):1356–1364.e2. doi: 10.1016/j.jaip.2021.12.038

Table E1.

Numbers and characteristics of patients with cMCAD and controls studied, by assay

Characteristic cMCADs: Whole cohort cMCADs: SARS-CoV-2 ELISpot assay cMCADs: Common coronavirus ELISpot assay cMCADs: Humoral assay Non-cMCADs: ELISpot assay MCAS: ELISpot assay
Number 32 22 18 15 32 11
Age (y), median (IQR) 50 (42-60) 51 (41-55) 51 (41-56) 52 (41-54) 52 (41-62) 40 (35-58)
Female/male sex ratio 19/13 13/9 9/9 8/7 16/16 10/1